Ensign Peak Advisors
BEAT

Ensign Peak Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Ensign Peak Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,237
Closed -$1.42M – 1909
2020
Q3 		$1.42M Hold
31,237
– – ﹤0.01% 1150
2020
Q2 		$1.41M Hold
31,237
– – ﹤0.01% 1144
2020
Q1 		$1.2M Hold
31,237
– – ﹤0.01% 1093
2019
Q4 		$1.45M Buy
+31,237
New +$1.35M ﹤0.01% 1195

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Ensign Peak Advisors's BEAT Position: Q4 2020 in Review

Ensign Peak Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 31,237 shares — an estimated $1.42M sold.

Ensign Peak Advisors first reported a position in BEAT in Q4 2019 and held it in 4 quarters. The position peaked at $1.45M in Q4 2019. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Ensign Peak Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 31,237 BioTelemetry, Inc. shares in Q4 2020, an estimated $1.42M.
  • Ensign Peak Advisors first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 4 quarters.
  • Ensign Peak Advisors's BioTelemetry, Inc. position peaked at $1.45M in Q4 2019.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Ensign Peak Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.